
Becton, Dickinson and Company BDX
$ 159.36
-0.17%
Quarterly report 2025-Q4
added 02-09-2026
Becton, Dickinson and Company Cash and Cash Equivalents 2011-2026 | BDX
Annual Cash and Cash Equivalents Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 641 M | 1.72 B | 1.48 B | 1.16 B | 2.39 B | 2.92 B | 536 M | 1.14 B | 14.2 B | 1.54 B | 1.42 B | 1.86 B | 1.89 B | 1.67 B | 1.18 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 B | 536 M | 2.38 B |
Quarterly Cash and Cash Equivalents Becton, Dickinson and Company
| 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 740 M | 735 M | 667 M | 813 M | 4.49 B | 2.39 B | 1.23 B | 1.02 B | 2.07 B | 744 M | 1.01 B | 2.76 B | 3.32 B | 2.05 B | 2.28 B | 3.15 B | 2.28 B | 3.25 B | 2.82 B | 2.82 B | 2.82 B | 560 M | 536 M | 536 M | 536 M | 943 M | 1.14 B | 1.14 B | 1.14 B | 1.12 B | 14.2 B | 14.2 B | 14.2 B | 919 M | 1.54 B | 1.54 B | 919 M | 1.58 B | 1.42 B | 1.42 B | 1.58 B | 8.54 B | 1.86 B | 1.86 B | 8.54 B | 1.68 B | 1.89 B | 1.89 B | 1.68 B | 1.92 B | 1.67 B | 1.67 B | 1.92 B | 2.2 B | 1.18 B | 1.18 B | 2.2 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 B | 536 M | 2.57 B |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
167 M | $ 29.85 | 1.05 % | $ 1.43 B | ||
|
AngioDynamics
ANGO
|
55.9 M | $ 10.6 | -1.03 % | $ 433 M | ||
|
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M | ||
|
Harvard Bioscience
HBIO
|
4.28 M | $ 0.47 | -4.15 % | $ 19.9 M | ||
|
Alcon
ALC
|
1.53 B | $ 77.32 | -1.5 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
308 M | $ 125.85 | -2.28 % | $ 3.1 B | ||
|
InfuSystem Holdings
INFU
|
165 K | $ 9.31 | -0.85 % | $ 192 M | ||
|
iRhythm Technologies
IRTC
|
236 M | $ 113.0 | -1.46 % | $ 3.62 B | ||
|
Intuitive Surgical
ISRG
|
3.37 B | $ 472.16 | -1.48 % | $ 169 B | ||
|
The Cooper Companies
COO
|
111 M | $ 69.92 | -2.24 % | $ 13.9 B | ||
|
Glaukos Corporation
GKOS
|
93.5 M | $ 97.02 | -0.79 % | $ 4.7 B | ||
|
Haemonetics Corporation
HAE
|
307 M | $ 59.92 | 0.72 % | $ 3.02 B | ||
|
electroCore
ECOR
|
10.3 M | $ 6.14 | -3.0 % | $ 33.9 K | ||
|
Masimo Corporation
MASI
|
178 M | $ 175.49 | -0.01 % | $ 9.35 B | ||
|
Isoray
ISR
|
61.6 M | - | 0.03 % | $ 108 M | ||
|
Predictive Oncology
POAI
|
735 K | - | - | $ 31.1 M | ||
|
Ekso Bionics Holdings
EKSO
|
1.17 M | $ 11.56 | -2.12 % | $ 28 M | ||
|
Repro Med Systems
KRMD
|
8.87 M | $ 4.28 | -0.7 % | $ 198 M | ||
|
Baxter International
BAX
|
1.97 B | $ 17.4 | -3.36 % | $ 8.93 B | ||
|
BioLife Solutions
BLFS
|
95.4 M | $ 18.36 | 1.16 % | $ 846 M | ||
|
Nephros
NEPH
|
4.31 M | $ 3.5 | -7.89 % | $ 36.4 M | ||
|
ResMed
RMD
|
274 M | $ 230.84 | -0.68 % | $ 33.7 B | ||
|
Retractable Technologies
RVP
|
4.24 M | $ 0.71 | 2.62 % | $ 21.3 M | ||
|
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | ||
|
Merit Medical Systems
MMSI
|
446 M | $ 69.95 | 2.61 % | $ 4.14 B | ||
|
Envista Holdings Corporation
NVST
|
1.21 B | $ 24.61 | -3.26 % | $ 4.13 B | ||
|
STAAR Surgical Company
STAA
|
153 M | $ 18.84 | 2.45 % | $ 934 M | ||
|
Stereotaxis
STXS
|
13.4 M | $ 1.89 | 0.27 % | $ 172 M | ||
|
Teleflex Incorporated
TFX
|
379 M | $ 107.32 | -0.87 % | $ 4.79 B | ||
|
OraSure Technologies
OSUR
|
199 M | $ 2.97 | -3.88 % | $ 218 M | ||
|
LeMaitre Vascular
LMAT
|
28.2 M | $ 108.06 | 1.43 % | $ 2.45 B | ||
|
Utah Medical Products
UTMD
|
92.9 M | $ 63.28 | 1.02 % | $ 230 M | ||
|
Pro-Dex
PDEX
|
419 K | $ 48.46 | 3.5 % | $ 159 M | ||
|
Microbot Medical
MBOT
|
2.47 M | $ 2.69 | -1.47 % | $ 27.4 M | ||
|
West Pharmaceutical Services
WST
|
791 M | $ 235.46 | 1.89 % | $ 17 B | ||
|
Repligen Corporation
RGEN
|
751 M | $ 114.2 | 0.39 % | $ 6.36 M | ||
|
DENTSPLY SIRONA
XRAY
|
326 M | $ 11.54 | -2.2 % | $ 2.3 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 21.57 | 1.27 % | $ 1.45 B | ||
|
STERIS plc
STE
|
172 M | $ 214.57 | 1.05 % | $ 21.2 B | ||
|
Milestone Scientific
MLSS
|
3.26 M | $ 0.28 | -3.75 % | $ 22.3 M |